Morgan Stanley Adjusts Ratings in Favor of Land Drillers HP, NEX and CLB
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/23/2024
- Wall Street closes higher as investors digest earnings, megacap outlook
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises as dollar slips, focus shifts to economic data
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
UPDATE: Morgan Stanley Downgrades Core Laboratories (CLB) to Underweight
September 26, 2022 5:23 AM EDT(Updated - September 26, 2022 5:25 AM EDT)
Morgan Stanley analyst Connor Lynagh downgraded Core Laboratories (NYSE: CLB) from Equalweight to Underweight with a price target of $20.00.
The analyst comments "Factors supporting our downgrade include that we see less upside EBITDA and FCF revisions potential for CLB relative to its peer group (FCF CLB: 7% / peers: 14%; EBITDA CLB:3% / peers: 9%), we see more... More
